Top

Published in:

Open Access 01-08-2011 | Research

Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock

Authors: Michael W Donnino, Michael N Cocchi, Justin D Salciccioli, Daniel Kim, Ali B Naini, Catherine Buettner, Praveen Akuthota

Published in: Critical Care | Issue 4/2011

Abstract

Introduction

Mitochondrial dysfunction is associated with increased mortality in septic shock. Coenzyme Q10 (CoQ10) is a key cofactor in the mitochondrial respiratory chain, but whether CoQ10 is depleted in septic shock remains unknown. Moreover, statin therapy may decrease CoQ10 levels, but whether this occurs acutely remains unknown. We measured CoQ10 levels in septic shock patients enrolled in a randomized trial of simvastatin versus placebo.

Methods

We conducted a post hoc analysis of a prospective, randomized trial of simvastatin versus placebo in patients with septic shock (ClinicalTrials.gov ID: NCT00676897). Adult patients with suspected or confirmed infection and the need for vasopressor support were included in the initial trial. For the current analysis, blood specimens were analyzed for plasma CoQ10 and low-density lipoprotein (LDL) levels. The relationship between CoQ10 levels and inflammatory and vascular endothelial biomarkers was assessed using either the Pearson or Spearman correlation coefficient.

Results

We analyzed 28 samples from 14 patients. CoQ10 levels were low, with a median of 0.49 (interquartile range 0.26 to 0.62) compared to levels in healthy control patients (CoQ10 = 0.95 μmol/L ± 0.29; P < 0.0001). Statin therapy had no effect on plasma CoQ10 levels over time (P = 0.13). There was a statistically significant relationship between plasma CoQ10 levels and levels of vascular cell adhesion molecule (VCAM) (r² = 0.2; P = 0.008), TNF-α (r² = 0.28; P = 0.004), IL-8 (r² = 0.21; P = 0.015), IL-10 (r² = 0.18; P = 0.025), E-selectin (r² = 0.17; P = -0.03), IL-1ra (r² = 0.21; P = 0.014), IL-6 (r² = 0.17; P = 0.029) and IL-2 (r² = 0.23; P = 0.009). After adjusting for LDL levels, there was a statistically significant inverse relationship between plasma CoQ10 levels and levels of VCAM (r² = 0.24; P = 0.01) (Figure 3) and IL-10 (r² = 0.24; P = 0.02).

Conclusions

CoQ10 levels are significantly lower in septic shock patients than in healthy controls. CoQ10 is negatively associated with vascular endothelial markers and inflammatory molecules, though this association diminishes after adjusting for LDL levels.

Available only for authorised users

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002PubMedCrossRef

Dare AJ, Phillips AR, Hickey AJ, Mittal A, Loveday B, Thompson N, Windsor JA: A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 2009, 47: 1517-1525. 10.1016/j.freeradbiomed.2009.08.019PubMedCrossRef

Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360: 219-223. 10.1016/S0140-6736(02)09459-XPubMedCrossRef

Harrois A, Huet O, Duranteau J: Alterations of mitochondrial function in sepsis and critical illness. Curr Opin Anaesthesiol 2009, 22: 143-149. 10.1097/ACO.0b013e328328d1ccPubMedCrossRef

Fink MP: Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001, 17: 219-237. 10.1016/S0749-0704(05)70161-5PubMedCrossRef

Tomasetti M, Alleva R, Solenghi MD, Littarru GP: Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 1999, 9: 231-240. 10.1002/biof.5520090218PubMedCrossRef

Rundek T, Naini A, Sacco R, Coates K, DiMauro S: Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 2004, 61: 889-892. 10.1001/archneur.61.6.889PubMedCrossRef

Hedenmalm K, Alvan G, Ohagen P, Dahl ML: Muscle toxicity with statins. Pharmacoepidemiol Drug Saf 2010, 19: 223-231. 10.1002/pds.1895PubMedCrossRef

Kwak B, Mulhaupt F, Myit S, Mach F: Statins as a newly recognized type of immunomodulator. Nat Med 2000, 6: 1399-1402. 10.1038/82219PubMedCrossRef

10.

Park SY, Lee JS, Ko YJ, Kim AR, Choi MK, Kwak MK, Choi HG, Yong CS, Kim JA: Inhibitory effect of simvastatin on the TNF-α- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation. Arch Pharm Res 2008, 31: 195-204. 10.1007/s12272-001-1141-2PubMedCrossRef

11.

Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG: Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007, 7: 358-368. 10.1016/S1473-3099(07)70111-1PubMedCrossRef

12.

Donnino MW, Cocchi MN, Howell M, Clardy P, Talmor D, Cataldo L, Chase M, Al-Marshad A, Ngo L, Shapiro NI: Statin therapy is associated with decreased mortality in patients with infection. Acad Emerg Med 2009, 16: 230-234. 10.1111/j.1553-2712.2009.00350.xPubMedCrossRef

13.

Littarru GP, Tiano L: Clinical aspects of coenzyme Q10: an update. Nutrition 2010, 26: 250-254. 10.1016/j.nut.2009.08.008PubMedCrossRef

14.

Brealey DA, Singer M, Terblanche M: Potential metabolic consequences of statins in sepsis. Crit Care Med 2011, 39: 1514-1520. 10.1097/CCM.0b013e31820eb74fPubMedCrossRef

15.

Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119: 771-778.PubMedCrossRef

16.

Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992, 215: 356-362. 10.1097/00000658-199204000-00009PubMedPubMedCentralCrossRef

17.

Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74: 1704-1710.PubMed

18.

Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest 1993, 103: 565-575. 10.1378/chest.103.2.565PubMedCrossRef

19.

Reinhart K, Bayer O, Brunkhorst F, Meisner M: Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002,30(5 Suppl):S302-S312.PubMedCrossRef

20.

Miles MV, Horn PS, Tang PH, Morrison JA, Miles L, DeGrauw T, Pesce AJ: Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta 2004, 347: 139-144. 10.1016/j.cccn.2004.04.003PubMedCrossRef

21.

Premkumar VG, Yuvaraj S, Vijayasarathy K, Gangadaran SG, Sachdanandam P: Serum cytokine levels of interleukin-1β, -6, -8, tumour necrosis factor-α and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q₁₀, riboflavin and niacin. Basic Clin Pharmacol Toxicol 2007, 100: 387-391. 10.1111/j.1742-7843.2007.00065.xPubMedCrossRef

22.

van Leeuwen HJ, Heezius ECJM, Dallinga GM, van Strijp JAG, Verhoef J, van Kessel KPM: Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003, 31: 1359-1366. 10.1097/01.CCM.0000059724.08290.51PubMedCrossRef

23.

Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L: Thiamine deficiency in critically ill patients with sepsis. J Crit Care 2010, 25: 576-581. 10.1016/j.jcrc.2010.03.003PubMedCrossRef

24.

Lelli JL, Drongowski RA, Gastman B, Remick DG, Coran AG: Effects of coenzyme Q10 on the mediator cascade of sepsis. Circ Shock 1993, 39: 178-187.PubMed

25.

Watts GF, Castelluccio C, Rice-Evans C, Taub NA, Baum H, Quinn PJ: Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin. J Clin Pathol 1993, 46: 1055-1057. 10.1136/jcp.46.11.1055PubMedPubMedCentralCrossRef

Title: Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock
Authors: Michael W Donnino
Michael N Cocchi
Justin D Salciccioli
Daniel Kim
Ali B Naini
Catherine Buettner
Praveen Akuthota
Publication date: 01-08-2011
Publisher: BioMed Central
Published in: Critical Care / Issue 4/2011
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc10343

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2011

Electrical impedance tomography measured at two thoracic levels can visualize the ventilation distribution changes at the bedside during a decremental positive end-expiratory lung pressure trial

A novel use for novel acute kidney injury biomarkers: fenoldopam's effect on neutrophil gelatinase-associated lipocalin and cystatin C

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome

Impact of norepinephrine on the relationship between pleth variability index and pulse pressure variations in ICU adult patients

Another nail in the hammer's coffin?

sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy